EuroEyes International Eye Clinic : CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPOSITION OF BOARD COMMITTEES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

EuroEyes International Eye Clinic Limited

德視佳國際眼科有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1846)

CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR

AND

COMPOSITION OF BOARD COMMITTEES

RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBER OF BOARD COMMITTEES

The board ("Board") of directors ("Director(s)") of EuroEyes International Eye Clinic Limited ("Company") announces that Mr. Zhengzheng Hu ("Mr. Hu") has tendered his resignation as an independent non-executive Director; and a member of each of the remuneration and the nomination committee of the Board with effect from 12 April 2021 due to his other business commitments.

Mr. Hu has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company ("Shareholders").

The Board would like to extend its sincere gratitude to Mr. Hu for his contribution to the Company during his tenure of office.

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBER OF BOARD COMMITTEES

The Board is pleased to announce that Ms. Katherine Rong Xin ("Ms Xin") has been appointed as an independent non-executive director of the Company and a member of each of the remuneration and the nomination committee of the Board with effect from 12 April 2021.

The biographical details of Ms. Xin are set out as follows:

Ms. Xin, aged 57, graduated from Auhui University (安徽大學) in July 1984 with a bachelor's

degree in English. She obtained a master's degree in applied linguistics from Graduate University of Chinese Academy of Sciences (中國科學院研究生院) in July 1986, and a master's degree in

business administration from California State University in June 1991. She further obtained a doctor's degree in business administration from the University of California in June 1995.

1

Currently, Ms. Xin is an independent non-executive director of Fosun Tourism Group (a company listed on the Main Board of The Stock Exchange of Hong Kong Limited (stock code: 1992)) and E Fund Management Co. Ltd. (a company established in Guangzhou, China with limited

liability), respectively. She has been a professor of management since September 2001 and Associate Dean since 2011 at the China Europe International Business School (中歐國際工商學

院). From August 2006 to December 2009, Ms. Xin worked as a professor of management at the International Institute for Management Development in Lausanne, Switzerland . She worked as an associate professor of management at The Hong Kong University of Science and Technology from September 1999 to August 2001. From September 1995 to August 1999, she served as an

assistant professor of management at the University of Southern California. Ms. Xin served as an independent director in Shanghai Blossom Hill Hotel Management Co. Ltd., (上海布洛斯酒店管理

有限公司), a company mainly engaged in boutique hotel management in China under the Blossom Hill (花間堂) brand, from March 2012 to April 2017. Ms. Xin was awarded the Chinese Most Cited Researchers by Elsevier, a global provider of scientific, technical, and medical information, for six consecutive years from 2014 to 2019.

Ms. Xin has entered into a letter of appointment with the Company for a term of two years. She will hold office until the next annual general meeting of the Company and is thereafter subject to retirement by rotation and re-election in accordance with the articles of association of the Company. Ms. Xin will be entitled to receive an annual director's fee of HK$360,000 which is determined by the Board based on the recommendation of the remuneration committee of the Board and by reference to her duties and responsibilities and prevailing market conditions.

Save as disclosed above, Ms. Xin does not hold any directorship in any other listed public companies, the securities of which are listed on any securities market in Hong Kong or overseas, in the last three years and does not have any relationship with any Directors, senior management or substantial or controlling shareholders of the Company. As at the date of this announcement, Ms. Xin does not have any interest or short position in the shares, underlying shares and/or debentures of the Company or any of its associated corporations within the meaning of Part XV of the Securities and Futures Ordinance, Chapter 571 of the Laws of Hong Kong ("SFO").

Ms. Xin has confirmed that she has met the independence criteria as set out under Rule 3.13 of the Rules Governing the Listing of Securities on the Stock Exchange ("Listing Rules"). Save as disclosed above, there are no other matters relating to Ms. Xin's appointment which need to be brought to the attention of the shareholders of the Company and there is no information to be disclosed pursuant to the requirements under Rule 13.51(2)(h) to (v) of the Listing Rules.

The Board extends its warm welcome to Ms. Xin.

2

Following the appointment of Ms. Xin, the Company has eight directors comprise four executive directors, one non-executive directors and three independent non-executive directors. As a result, the number of independent non-executive directors of the Board has fulfilled the minimum number as required under Rules 3.10(1) and 3.10A of the Listing Rules.

By order of the Board of

EuroEyes International Eye Clinic Limited

Dr. Jørn Slot Jørgensen

Chairman and Executive Director

12 April 2021

As at the date of this announcement, the Board comprises Dr. Jørn Slot Jørgensen, Dr. Markus Braun, Dr. Ralf-Christian Lerche, Mr. Jannik Jonas Slot Jørgensen as executive Directors; Mr. Marcus Huascar Bracklo as non-executive Director; Mr. Hans Helmuth Hennig, Mr. Philip Duncan Wright and Ms. Katherine Rong Xin as independent non-executive Directors.

3